- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: AMA Wants to Ban TV Ads for Drugs
What we're reading, November 19, 2015: the American Medical Association is calling for a ban on direct-to-consumer television advertisement of prescription drugs and popular silver plans on HealthCare.gov have largest premium increases.
AMA Calls for Ban on TV Advertising of Drugs, Devices
Physicians at the Interim Meeting of the American Medical Association (AMA) supported an advertising ban based on concerns that the increase of direct-to-consumer advertising of prescription drugs is driving demand for expensive treatments despite the fact that there are clinically effective, less costly options. Currently, the US and New Zealand are the only 2 countries that allow direct-to-consumer advertising of prescription drugs.
Most Popular ACA Plans See Large Premium Increases
The most popular plans purchased through HealthCare.gov are the silver plans, and a new analysis from The Wall Street Journal has found that premiums for these plans are rising double-digit percentages in 20 state-capital counties. Another 10 states are seeing increases that are more modest. In the majority (17) of the states with increases, consumers don’t even have the option of switching to another insurer and paying a lower premium. The best they can do is switch to a plan with a smaller increase.
Businesses With Less Than 50 Workers Face Tough Decisions Due to ACA
As businesses with 50 or more full-time equivalent employees become required to offer workers health insurance or face penalties, small businesses on the edge are faced with the decision of whether they can afford to grow their companies, reports The New York Times. While nearly all large companies provide healthcare benefits, just more than half (54%) of businesses with 3 to 49 workers offer that coverage.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
